VALPOSAFE 300CR

COMPOSITION - Sodium Valproate 200 mg + Valproic Acid 87 mg (Controlled Release) Tablets

DESCRIPTION - VALPOSAFE 300 CR is a controlled-release anticonvulsant formulation. Sodium valproate and valproic acid increase gamma-aminobutyric acid (GABA) levels in the brain, enhancing inhibitory neurotransmission and stabilizing neuronal activity. This reduces abnormal electrical discharges responsible for seizures. The controlled-release formulation provides sustained plasma levels for improved seizure control and better patient compliance.

Uses 

• Epilepsy

• Generalized seizures

• Partial seizures

• Neurological seizure disorders

• Bipolar disorder (as mood stabilizer)

Side Effects

• Nausea

• Weight gain

• Tremors

• Drowsiness

• Hair loss (temporary)

Precautions / Other Important Details 

• Monitor liver function during therapy

• Use cautiously in patients with liver disease

• Avoid abrupt discontinuation

• Not recommended during pregnancy (risk of fetal harm)

• Regular monitoring of blood levels may be required